Search research articles
Contact Us
Filters
Showing results (711-720 of 757) with videos related to
Page
of 76
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)
|
October 31, 2013
A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1
Haidan Liu, Joonsung Hwang, Wei Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 8, 2018
The Ashitaba (<i>Angelica keiskei</i>) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K
Tianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, et al.
Experimental Dermatology
|
April 29, 2017
PKCι is a target of 7,8,4'-trihydroxyisoflavone for the suppression of UVB-induced MMP-1 expression
Tae-Gyu Lim, Yoon-A Kim, Jong-Eun Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 2017
RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth
Ke Yao, Cong Peng, Yuwen Zhang, et al.
Molecular Cancer Therapeutics
|
March 29, 2013
Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo
Hua Xie, Mee-Hyun Lee, Feng Zhu, et al.
Journal of the American Heart Association
|
July 16, 2019
Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease
Roman N Rodionov, Hoshimjon Begmatov, Natalia Jarzebska, et al.
Stem Cell Research
|
May 6, 2014
ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal
Sung-Hyun Kim, Myoung Ok Kim, Yong-Yeon Cho, et al.
Journal of Molecular Biology
|
November 13, 2012
Structural and functional analysis of the natural JNK1 inhibitor quercetagetin
Sohee Baek, Nam Joo Kang, Grzegorz M Popowicz, et al.
Theranostics
|
May 4, 2018
Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy
Zheqiong Tan, Lanbo Xiao, Min Tang, et al.
Carcinogenesis
|
September 11, 2012
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
Xiang Li, Haitao Li, Shengqing Li, et al.
Page
of 76
Search research articles
Search
Showing results (711-720 of 757) with videos related to
Sort By:
Page
of 76
Cancer Prevention Research (Philadelphia, Pa.)
|
October 31, 2013
A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1
Haidan Liu, Joonsung Hwang, Wei Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 8, 2018
The Ashitaba (<i>Angelica keiskei</i>) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K
Tianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, et al.
Experimental Dermatology
|
April 29, 2017
PKCι is a target of 7,8,4'-trihydroxyisoflavone for the suppression of UVB-induced MMP-1 expression
Tae-Gyu Lim, Yoon-A Kim, Jong-Eun Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 2017
RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth
Ke Yao, Cong Peng, Yuwen Zhang, et al.
Molecular Cancer Therapeutics
|
March 29, 2013
Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo
Hua Xie, Mee-Hyun Lee, Feng Zhu, et al.
Journal of the American Heart Association
|
July 16, 2019
Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease
Roman N Rodionov, Hoshimjon Begmatov, Natalia Jarzebska, et al.
Stem Cell Research
|
May 6, 2014
ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal
Sung-Hyun Kim, Myoung Ok Kim, Yong-Yeon Cho, et al.
Journal of Molecular Biology
|
November 13, 2012
Structural and functional analysis of the natural JNK1 inhibitor quercetagetin
Sohee Baek, Nam Joo Kang, Grzegorz M Popowicz, et al.
Theranostics
|
May 4, 2018
Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy
Zheqiong Tan, Lanbo Xiao, Min Tang, et al.
Carcinogenesis
|
September 11, 2012
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
Xiang Li, Haitao Li, Shengqing Li, et al.
Page
of 76